My personalised skin cancer jab is the best chance of stopping it for 200d, Says patient

One of the first patients to try a game-changing skin cancer jab today said: “This is my best chance at stopping it in its tracks.”

- John Dunne

Steve Young, 52, from Stevenage, Hertfordshire, is taking part in trials for the world’s first personalised mRNA cancer jab for melanoma, which also has the potential to stop lung, bladder and kidney cancers. The jab, which offers hope of a cure, is custom-built for each person in just a few weeks.

It works by telling the body to hunt down cancer cells and prevent the deadly disease from coming back.

A stage two trial of the jab, involving pharma firms Moderna and MSD, found it dramatically reduced the risk of the cancer returning in melanoma patients. Mr Young, pictured, is among British patients taking part in the final phase three trial, led by University College London Hospitals NHS Foundation Trust.